
Xin Chen, Ph.D.
VP, Head of Global Regulatory Affairs @ InnoCare Pharma
United States
New York City Metropolitan Area
Pharmaceuticals
Pharmaceutical Industry, Regulatory Affairs, Drug Discovery, Global Drug Development, Pharmacology, Drug Development, Medicinal Chemistry, Biomarkers, Drug Design, In Vitro, In Vivo, Oncology, Ophthalmology, Pharmacokinetics, ICH guidelines, FDA, Clinical Development, Clinical Operations, Life Sciences
Experience

Global Regulatory Affairs Leader
Greater New York City Area
• Regulatory strategist for programs in immunoinflammation, rare blood disease, oncology, diabetes, cardiovascular, ophthalmology therapeutic areas and modalities of small molecule, protein, antibody, gene/cell therapy and medical device • Developing and implement regulatory strategies for projects in the US, EU and ROW in various therapeutic areas • Leading Pre-IND interactions, IND filing, NDA/BLA filing, end-of-phase meetings with Agency • Managing regulatory submissions and periodic reports (DSUR, NDA/BLA Annual Report, PSUR/PBRER) • Rare disease and orphan drug product regulatory development • Gene therapy product development (viral-based and ex-vivo gene editing-based) • Breakthrough Therapy Designation • Pediatric development and requirement • Biosimilar development; interchangeability requirement • Due diligence regulatory evaluation
Xin Chen, Ph.D.'s Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.







